Pages
Products
Panoply™ Human CD40 Knockdown Stable Cell Line

Panoply™ Human CD40 Knockdown Stable Cell Line

Cat.No. :  CSC-DC002750

Host Cell:  HEK293 (Hela and other cell types are also available) Validation:  Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Informationn

Cat. No. CSC-DC002750
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Gene CD40
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Stability Validated for at least 10 passages
Application

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Size Form >1 × 10^6 cells / vial
Shipping Dry Ice
Storage Liquid Nitrogen
Gene Name
Gene Symbol
Synonyms
Gene Description
Gene ID
UniProt ID
mRNA Refseq
Protein Refseq
Chromosome Location
Function
Pathway
MIM
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Case Study

Publications

Q & A

Customer Reviews

CD40 expression in esophageal cancer (EC) is associated with poor prognosis, although its molecular role remains unclear. Here, researchers explored the role of CD40 in EC progression and metastasis, focusing on its interaction with CD154 and upregulation of MMP-9. CD40 expression in EC cell lines was confirmed using quantitative PCR, western blotting, flow cytometry, and immunocytochemistry. Functional assays demonstrated that stimulation with recombinant soluble CD154 enhanced the migration and invasion of CD40-overexpressing EC cells without affecting their viability. Co-culture experiments with platelets demonstrated that platelet-derived CD154 acted on CD40-overexpressing esophageal cancer cells, resulting in upregulated MMP-9 secretion, which may drive tumor invasion. Analysis of serum from patients undergoing esophagectomy revealed that lower MMP-9 levels were associated with longer survival in patients with pathological stage I, while the opposite trend was observed in patients with stages II-IV. These results suggest that activation of CD40 enhances tumor cell invasiveness through upregulation of MMP-9. This dual role of CD40, enhancing antitumor immunity through expression on antigen-presenting cells while promoting tumor invasion through secretion of MMP-9 when expressed on esophageal cancer cells, may complicate immunotherapeutic strategies targeting CD40, as such interventions may inadvertently promote malignancy in the tumor microenvironment.

To clarify the role of the CD40 gene in TE cells, the researchers constructed CD40 knockdown TE-10 cells. TE-10 cells were transfected with si-CD40 or si-control to generate CD40 knockdown TE-10 cells and control TE-10 cells (Mock), respectively. Then, the knockdown efficiency was evaluated by measuring CD40 mRNA levels by qPCR (Figure 1A). In addition, the researchers also evaluated the response of these cells to sCD154 stimulation by measuring MMP-9 mRNA levels. Regardless of sCD154 stimulation or not, CD40 knockdown TE-10 cells always maintained low MMP-9 mRNA levels (Figure 1B). In addition, migration and invasion experiments were performed using CD40 knockdown TE-10 cells. The results showed that CD40 knockdown TE-10 cells exhibited reduced migration and invasion abilities compared with control cells (Figure 1C and D).

Figure 1. Experiments using CD40-knockdown TE-10 cells using siRNA. (Umemoto K, et al., 2025)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER